Crescent Capital BDC, Inc. — fact timeline

Crescent Capital BDC, Inc. amended Ninth Amendment to Loan and Security Agreement with Wells Fargo Bank, National Association valued at $500.0 million (effective 2026-05-21).

“On May 21, 2026, Crescent Capital BDC Funding, LLC, a wholly owned subsidiary of Crescent Capital BDC, Inc. (the “Company”), entered into the Ninth Amendment to Loan and Security Agreement (the “Amendment”), which amends the Loan and Security Agreement, dated as of March 28, 2016, by and among the Company, as collateral manager, Crescent Capital BDC Funding, LLC, as borrower, and Wells Fargo Bank, National Association, as administrative agent, collateral agent, and lender.”

Crescent Capital BDC, Inc. shareholders approved Ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-15 meeting.

“The following votes were taken in connection with the proposal: For Against Abstained 26,529,354 211,437 155,426”

Crescent Capital BDC, Inc. shareholders approved Election of Class I Directors at the 2026-05-15 meeting.

“The following votes were taken in connection with the proposal: Director For Against Abstain Broker Non-Votes Susan Yun Lee 17,107,252 306,098 107,901 Michael S. Segal 16,302,024 1,113,132 106,095”

Crescent Capital BDC, Inc. reported financial results for the quarter ended March 31, 2026.

“On May 13, 2026, Crescent Capital BDC, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026.”

Henry Chung was elected as Class III director at Crescent Capital BDC, Inc..

“On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Henry Chung as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified.”

Jason Breaux was elected as Class III director, Chairman of the Board at Crescent Capital BDC, Inc..

“On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Jason Breaux as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified.”

Elizabeth Ko resigned as Class III Director at Crescent Capital BDC, Inc..

“On and effective as of 12:00 a.m. midnight on May 5, 2026, the Board of Directors (the “Board”) of Crescent Capital BDC, Inc. (the “Company”) accepted the resignation of Elizabeth Ko as a member of the Board and a Class III Director.”

Crescent Capital BDC, Inc. shareholders approved Ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-10 meeting.

“Proposal 2 – Ratify the selection of Ernst & Young LLP (“E&Y”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Stockholders approved a proposal to authorize Ernst & Young LLP (“E&Y”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The following votes were taken in connection with the proposal: For Against Abstained Broker Non-Votes 24,014,738 133,771 115,225 n/a”

Crescent Capital BDC, Inc. shareholders approved Election of Class III Directors at the 2024-05-10 meeting.

“Proposal 1 – Election of Class III Directors. The following individuals, constituting all of the Class III nominees named in the Company’s Proxy Statement relating to the Annual Meeting, as filed with the Securities and Exchange Commission on March 26, 2024 (the “Proxy Statement”), were elected as Class III Directors of the Company. Elizabeth Ko and Steven F. Strandberg were elected as Class III Directors of the Company to serve for a three-year term expiring at the 2027 annual meeting of stockholders or until their respective successor is duly elected and qualified. The following votes were taken in connection with the proposal: Director For Withheld Broker Non-Votes Elizabeth Ko 17,157,771 193,647 6,912,316 Steven F. Strandberg 17,028,438 322,980 6,912,316”

Crescent Capital BDC, Inc. reported the quarter ended March 31, 2024 results: EPS $0.63 per share.

“Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.63 per share and net income of $0.76 per share for the quarter ended March 31, 2024.”

Crescent Capital BDC, Inc. reported financial results for the quarter and year ended December 31, 2023.

“On February 21, 2024, Crescent Capital BDC, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and year ended December 31, 2023.”

Jason Breaux changed role as President at Crescent Capital BDC, Inc..

“Mr. Chung succeeds Jason Breaux as the Company’s President. Mr. Breaux continues in his role as the Company’s Chief Executive Officer.”

Henry Chung was appointed as President at Crescent Capital BDC, Inc..

“Effective February 15, 2024, the Board of Directors of the Company appointed Henry Chung, age 36, as its President.”

Crescent Capital BDC, Inc. reported the quarter ended September 30, 2023 results: net income $21.7 million, or $0.59 per share, EPS $0.59 per share.

“On November 8, 2023, the Registrant issued a press release announcing its financial results for the quarter ended September 30, 2023.”

Crescent Capital BDC, Inc. incurred senior notes of $50 million with Qualified Institutional Investors at 7.54% maturing July 28, 2026.

“On July 28, 2023, Crescent Capital BDC, Inc., a Maryland corporation (the “ Company ”) issued approximately $50 million in aggregate principal amount of 7.54% senior unsecured notes due July 28, 2026 (the “ Series 2023A Notes ”)”

Crescent Capital BDC, Inc. terminated Series 2020A Notes valued at $50 million (effective 2023-07-28).

“The Company also repaid all outstanding indebtedness and interest on $50 million in aggregate principal amount of its 5.95% senior unsecured notes due July 30, 2023 (the “ Series 2020A Notes ”).”

Crescent Capital BDC, Inc. entered into Second Supplement to the Note Purchase Agreement with qualified institutional investors named therein valued at approximately $50 million (effective 2023-05-08).

“the Company, entered into a Second Supplement to the Note Purchase Agreement (the “ Second Supplement ”) by and among the Company, the qualified institutional investors named therein (the “ Series 2023A Additional Purchasers ”) governing the issuance of the 2023A Notes”

Crescent Capital BDC, Inc. shareholders approved Ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-05-12 meeting.

“Proposal 2 – Ratify the selection of Ernst & Young LLP (“E&Y”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Stockholders approved a proposal to authorize E&Y as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The following votes were taken in connection with the proposal: For Against Abstained Broker Non-Votes 25,419,744 187,628 83,160 n/a”

Crescent Capital BDC, Inc. shareholders approved Election of Class II Directors at the 2023-05-12 meeting.

“Proposal 1 – Election of Class II Directors. The following individuals, constituting all of the Class II nominees named in the Company’s Proxy Statement relating to the Annual Meeting, as filed with the Securities and Exchange Commission on March 28, 2023, were elected as Class II Directors of the Company. Susan Y. Lee and Michael S. Segal were elected as Class II Directors of the Company to serve for a three-year term expiring at the 2026 annual meeting of stockholders or until their respective successor is duly elected and qualified. The following votes were taken in connection with the proposal: Director For Withheld Broker Non-Votes Susan Y. Lee 18,420,510 369,971 6,900,051 Michael S. Segal 18,365,353 425,128 6,900,051”

Crescent Capital BDC, Inc. reported the quarter ended March 31, 2023 results: net income $17.5 million, EPS $0.54 per share.

“Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $17.5 million, or $0.54 per share, for the quarter ended March 31, 2023.”

Crescent Capital BDC, Inc. completed an acquisition involving First Eagle Alternative Capital BDC, Inc. for cash and shares of CCAP common stock (closed 2023-03-09).

“On March 9, 2023, Crescent Capital BDC, Inc, a Maryland corporation (“CCAP”) completed its previously announced acquisition of First Eagle Alternative Capital BDC, Inc., a Delaware corporation (“FCRD”), pursuant to the Agreement and Plan of Merger”

Crescent Capital BDC, Inc. incurred senior notes of $111.6 million with U.S. Bank National Association at 5.00% per year maturing May 25, 2026.

“On March 9, 2023, CCAP entered into a fifth supplemental indenture (the "Fifth Supplemental Indenture") by and between CCAP and U.S. Bank National Association, as trustee (the "Trustee"), effective as of the closing of the Third Merger. The Fifth Supplemental Indenture relates to CCAP's assumption of $111.6 million in aggregate principal amount of FCRD's 5.00% Notes due 2026 (the "Notes").”

Crescent Capital BDC, Inc. amended Sixth Amendment to Loan and Security Agreement with Wells Fargo Bank, National Association valued at $500 million (effective 2023-03-07).

“On March 7, 2023, Crescent Capital BDC, Inc., a Maryland corporation (“CCAP”), and Crescent Capital BDC Funding, LLC (“CCAP SPV”), a wholly-owned subsidiary of CCAP, entered into the Sixth Amendment to Loan and Security Agreement (the “Amendment”), by and among CCAP, as the collateral manager, seller and equity holder, CCAP SPV, as the borrower, and Wells Fargo Bank, National Association, as administrative agent, collateral agent, and lender, which amends the Loan and Security Agreement, dated as of March 28, 2016”

Crescent Capital BDC, Inc. reported the quarter ended December 31, 2022 results: revenue $ 34.6, net income $ 16.1, EPS $0.52 per share.

“Investment income $ 34.6 $ 29.0 $ 24.1 Net investment income $ 16.1 $ 16.0 $ 12.5 Net realized gains (losses), net of taxes $ (0.0 ) $ (2.5 ) $ (0.4 ) Net change in unrealized gains (losses), net of taxes $ (13.5 ) $ (15.8 ) $ 0.7 Net increase (decrease) in net assets resulting from operations $ 2.6 $ (2.4 ) $ 12.8 Net investment income per share $ 0.52 $ 0.52 $ 0.42”

Crescent Capital BDC, Inc. reported the year ended December 31, 2022 results: net income $59.7 million, EPS $1.93 per share.

“Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $59.7 million, or $1.93 per share, and adjusted net investment income of $53.4 million, or $1.73 per share, for the year ended December 31, 2022.”

Crescent Capital BDC, Inc. amended First Omnibus Amendment to the Senior Secured Revolving Credit Agreement and Guarantee and Security Agreement with Sumitomo Mitsui Banking Corporation valued at increased the size of the Revolving Credit Facility from $350 million to $385 million (effective 2023-01-13).

“On January 13, 2023, Crescent Capital BDC, Inc. (the “Company”), and certain subsidiaries of the Company, entered into an amendment (the “Credit Facility Amendment”) to the documents governing the Company’s Senior Secured Revolving Credit Facility (the “Revolving Credit Facility”) with Sumitomo Mitsui Banking Corporation as Administrative Agent, Collateral Agent, and lender, and certain other lenders named therein.”

Crescent Capital BDC, Inc. reported the quarter ended September 30, 2022 results: revenue $29.0, net income $16.0 million, EPS $0.52 per share.

“$ 1,285.3 $ 1,138.6 Total assets $ 1,339.3 $ 1,323.0 $ 1,183.2 Total net assets $ 622.6 $ 639.2 $ 596.2 Net asset value per share $ 20.16 $ 20.69 $ 21.16 Investment income $ 29.0 $ 26.7 $ 25.5 Net investment income $ 16.0 $ 15.5 $ 12.7 Net realized gains (losses), net of taxes $ (2.5 ) $ (1.8 ) $ 27.9 Net change in unrealized gains (losses), net of taxes $”

Erik Barrios was appointed as Chief Compliance Officer at Crescent Capital BDC, Inc..

“Additionally, as of the Effective Date, the Board appointed Erik Barrios as the Company's Chief Compliance Officer.”

Joe Hanlon resigned as Chief Compliance Officer at Crescent Capital BDC, Inc..

“On and effective as of November 4, 2022 (the "Effective Date"), the Board of Directors (the "Board") of Crescent Capital BDC, Inc. (the "Company") accepted the resignation of Joe Hanlon as the Chief Compliance Officer.”

Susan Yun Lee was appointed as independent Class II director at Crescent Capital BDC, Inc..

“appointed Susan Yun Lee as an independent Class II director to fill the vacancy created by such increase.”

Elizabeth E. Ko was elected as Class III director and Chairman of the Board at Crescent Capital BDC, Inc..

“the Board elected Ms. Elizabeth E. Ko as a Class III director, which is the class of directors that will stand for election at the Company’s 2024 Annual Meeting of Stockholders, or until a successor is duly elected and qualified. Ms. Ko, who will serve as Chairman of the Board”

Jason A. Breaux was appointed as President at Crescent Capital BDC, Inc..

“the Board appointed Jason A. Breaux as the Company’s President.”

Christopher G. Wright resigned as member of the Board at Crescent Capital BDC, Inc..

“the Board of Directors (the “Board”) of Crescent Capital BDC, Inc. (the “Company”) accepted the resignation of Christopher G. Wright as a member of the Board.”